-
2024-519152-82-00
5
2025-09-03
Relapsed/Refractory Follicular Lymphoma
-
2025-520519-14-00
5
2025-09-03
Atherosclerotic Cardiovascular Disease
-
2024-518154-16-00
5
2025-08-27
non-small cell lung cancer
-
2024-518914-18-00
4
2025-08-27
Moderate to Severely Active Ulcerative Colitis & Moderate to Severely
-
2024-519525-38-00
5
2025-08-22
Heart failure
-
2024-519928-24-00
4
2025-08-21
Myelodysplastic Syndrome
-
2023-507071-21-01
1
2025-08-14
Relapsed/Refractory Multiple Myeloma
-
2024-512937-34-00
6
2025-08-06
RECURRENT LOWER RESPIRATORY TRACT INFECTIONS (RLRTIS).
-
2024-519499-22-00
1
2025-08-04
Advanced or Metastatic Hepatocellular Carcinoma
-
2023-509630-19-00
5
2025-07-31
Esophageal Squamous Cell Carcinoma (ESCC)
-
2024-512583-57-00
5
2025-07-30
HER2-positive locally advanced or metastatic gastric or gastroesophage
-
2024-519521-37-01
10
2025-07-30
Acute ischemic stroke
-
2024-520154-38-00
5
2025-07-29
Acute Myeloid Luekemia
-
2024-511667-28-00
1
2025-07-21
Plasma cell myeloma refractory
-
2024-519322-20-00
5
2025-07-21
metastatic colorectal cancer
-
2024-516162-11-00
5
2025-07-14
Endocrine-Sensitive phosphatidylinositol 3-kinase (PIK3CA)-Mutated, Ho
-
2024-512981-33-00
4
2025-07-09
Metastatic Colorectal Cancer
-
2024-519282-22-00
5
2025-07-09
Chronic Hepatitis D Virus (HDV) Infection
-
2024-517247-31-00
5
2025-07-07
Newly Diagnosed Higher Risk Myelodysplastic Syndrome
-
2024-517789-41-00
6
2025-07-04
metastatic or locally advanced renal cell carcinoma
-
2024-518289-28-00
4
2025-07-04
Progressive pulmonary fibrosis [PPF]
Idiopathic pulmonary fibrosis [I
-
2024-516633-12-00
5
2025-06-30
Locally advanced/ metastatic gastroesophageal junction and gastric can
-
2024-514539-67-00
4
2025-06-27
Systemic Sclerosis
-
2024-513111-27-00
5
2025-06-26
Psoriatic Arthritis